Upcoming events
EFMC International Symposium on Medicinal Chemistry 2026
In person
At the upcoming EFMC conference in Basel, Masa Kobayashi, Head of Assay Development and Screening at ZoBio, will present the poster:
“Tailor-made Biophysics – A Versatile Toolkit for Discovery and Validation.”
The poster will showcase selected case studies demonstrating how flexible biophysical strategies can help address diverse discovery challenges from fragment-based screening for molecular glues and the profiling of covalent compounds to the characterization of antibody–antigen interactions and the generation of structural models when X-ray crystallography reaches its limits.
These examples highlight the power of a tailor-made approach: adapting the biophysical toolkit to the scientific question at hand to generate meaningful insights and help move discovery programs forward.
Because drug discovery rarely follows a straight line, ZoBio tailors its biophysical strategies and scientific expertise to each challenge helping you find the right path and, ultimately, the right molecule.
Heading to EFMC Basel and want to know more? We would love to connect.
10th RSC-BMCS Fragment-based Drug Discovery Meeting
In person
ZoBio is pleased to attend the RSC-BMCS Fragment-Based Drug Discovery meeting in Cambridge this September.
The meeting brings together scientists from across academia, biotechnology, and the pharmaceutical industry to discuss advances and impactful applications of fragment-based drug discovery.
ZoBio will be represented by Johan Veerman, Head of Chemistry, who will also present a poster entitled:
Site-selective screening: Design, synthesis and application of stable S-adenosylmethionine-based probes for fragment screening against METTL3/14
We look forward to sharing our work, exchanging ideas with the fragment-based drug discovery community, and connecting with fellow scientists in Cambridge.
16th Swiss Course on Medicinal Chemistry in Leysin
In person
As in previous years, ZoBio is proud to be part of the 16th Swiss Course on Medicinal Chemistry in Leysin!
This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies and technologies that support hit generation, lead finding, and lead optimization campaigns.
The course content is tailored for young scientists working in medicinal chemistry, as well as those from related disciplines such as biochemistry, pharmacy, pharmacology, or biophysics, from both the pharmaceutical and biotech industries.
Also our scientists are excited to contribute to this special event. On Thursday, October 8th, Stephan Theisgen will present a talk on the application of NMR in modern drug discovery. Additionally, Marta Carneiro (Head of Structural Biology) and Johan Veerman (Head of Chemistry) will share their expertise on the use of biophysics in various aspects of drug discovery with the next generation of drug hunters.
Looking forward to meeting you in Leysin!
Past events
EUROMAR 2026
In person
As in the previous years ZoBio attended the European Conference on Magnetic Resonance, which took place in Göteborg, Sweden.
Stephan Theisgen presented a poster demonstrating how strategically integrating solution-state NMR into commercial drug discovery programs provides critical structural insights across the early preclinical pipeline.
The poster highlighted how NMR complements biochemical assays, biophysical screening, AI-driven modeling, X-ray crystallography, and cryo-EM by delivering dynamic, site-specific information on ligand–target interactions. Practical examples showcase the application of NMR for fragment screening, cryptic pocket identification, hit validation, rapid verification of computational and structural models, and overcoming crystallization challenges.
By implementing scalable and cost-effective NMR workflows with rapid turnaround times, ZoBio enables clients to make informed decisions and confidently advance their small-molecule discovery programs.
Interested in learning how solution-state NMR can support your drug discovery? Contact us!
RICT 2026
In person
ZoBio attended the 60th edition of the RICT Conference in Paris, where our colleague Anne-Sophie Huart presented a poster highlighting how flexible biophysical strategies could be applied across a broad range of discovery challenges.
The poster showcased how tailored biophysical workflows could:
- Support hit identification across multiple modalities
- Enable a deeper mechanistic understanding of interactions
- Improve confidence in early-stage validation strategies
- Adapt to complex or unconventional drug discovery targets
It was a great opportunity to connect with the medicinal chemistry community in Paris and discuss the role of biophysical approaches in modern drug discovery.
3rd Biophysics for Drug Discovery Summit 2026
In person
ZoBio attended the 3rd Biophysics for Drug Discovery Summit 2026 in Boston, a unique, industry-focused forum dedicated exclusively to biophysics. Through case studies, panel discussions, and interactive exchanges, the summit highlights how emerging biophysical technologies are shaping predictive pipelines and accelerating drug discovery.
Marta Carneiro presented the poster: “Tailor-made Biophysics – A versatile toolkit for discovery and validation”, which attracted a lot of attention during the meeting.
Marta shared selected case studies demonstrating how biophysical approaches can address diverse discovery challenges – from fragment-based screening for molecular glues, to profiling covalent compounds and antibody – antigen interactions, as well as generating structural models when X-ray crystallography reaches its limits.
Curious to see how these approaches can support complex discovery programs? Download the poster to explore the case studies and insights in more detail.